Journal of Antimicrobial Chemotherapy, Vol 39, 67-73, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
JT Mayne, NJ Johnson, WM Kluwe, DL Lencoski and RJ Polzer
Trovafloxacin, a broad-spectrum naphthyridone antimicrobial agent, was
evaluated for potential phototoxicity in a standardized in-vivo test system
that has been used previously to assess quinolone antibiotics. Fasted
BALB/c mice were given a single oral dose of either trovafloxacin mesylate
(10, 30, 90 or 250 mg/kg) or the positive control lomefloxacin
hydrochloride (71 mg/kg) and immediately exposed to long-wave ultraviolet
(UVA) light. Animals were irradiated for 4 h, equal to a total UV light
irradiation of approximately 18 J/cm2. Before dosing, at the end of the
irradiation period and at approximately 24, 48, 72 and 96 h after dosing,
both ears of each mouse were evaluated for changes indicative of a positive
response: erythema, oedema or a measurable increase in ear thickness. Under
the conditions of this study, trovafloxacin produced a mild response
(erythema and a slight increase in ear thickness) in mice given a dose of
90 or 250 mg/kg; no significant response was observed in mice given either
lower doses (10 or 30 mg/kg) or the vehicle. In contrast, 71 mg/kg of
lomefloxacin produced a strong and persistent phototoxic response. The
results of this study demonstrate that the phototoxic potential of
trovafloxacin is considerably less than that of lomefloxacin and, when
compared with similar studies with related compounds, suggest that
trovafloxacin is among the least phototoxic of the fluoroquinolone class.
ORIGINAL ARTICLES
A study of the phototoxic potential of trovafloxacin in BALB/c mice
Central Research Division, Pfizer Inc., Groton, CT 06340, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?